Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|March 7, 2001
Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitisM Volkmann, L Martin, A Bäurle, et al.Journal of Molecular Medicine (Berlin, Germany)|November 3, 2001
Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinomaM Volkmann, J H Schiff, Y Hajjar, et al.Klinische Wochenschrift|July 2, 1984
Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effectW P Bieger, R Dlugosch, A Rettenmeier, et al.Journal of Neurology|November 18, 2000
Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patientsM Schwaninger, P Ringleb, A Annecke, et al.Stroke|March 1, 1995
Recent infection as a risk factor for cerebrovascular ischemiaA J Grau, F Buggle, S Heindl, et al.Surgical Endoscopy|October 7, 2006
Effect of a pneumoperitoneum on systemic cytokine levels, bacterial translocation, and organ complications in a rat model of severe acute pancreatitis with infected necrosisO Strobel, D Wachter, J Werner, et al.Diabetes Care|December 24, 1997
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDMM A Hofmann, B Kohl, M S Zumbach, et al.Gut|November 21, 1998
First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptyingC M Oneta, U A Simanowski, M Martinez, et al.Anticancer Research|March 2, 2005
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancerB Werle, M Kotzsch, T T Lah, et al.Diabetes Care|May 20, 1998
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDMM A Hofmann, B Kohl, M S Zumbach, et al.Pageof 7